| Literature DB >> 27128367 |
Ken Uekawa1, Yu Hasegawa1, Satoru Senju2, Naomi Nakagata3, Mingjie Ma1, Takashi Nakagawa1, Nobutaka Koibuchi1, Shokei Kim-Mitsuyama1.
Abstract
This work was performed to test our hypothesis that angiotensin-(1-7) can ameliorate cognitive impairment and cerebrovascular reactivity in 5XFAD mice, a useful model of Alzheimer's disease. 5XFAD mice received intracerebroventricular infusion of (1) vehicle, (2) angiotensin-(1-7), or (3) angiotensin-(1-7)+A779, a specific Mas receptor antagonist, for 4 weeks. Angiotensin-(1-7), through Mas receptor, significantly ameliorated cognitive impairment in 5XFAD mice. As estimated by acetazolamide-induced increase in cerebral blood flow, angiotensin-(1-7), through Mas receptor, enhanced cerebrovascular reactivity in 5XFAD mice. In conclusion, angiotensin-(1-7)/Mas receptor axis improves cognitive function and cerebrovascular function in a mouse model of Alzheimer's disease.Entities:
Keywords: Acetazolamide; Mas receptor; angiotensin-(1–7); cognitive function; vascular reactivity; water maze test
Mesh:
Substances:
Year: 2016 PMID: 27128367 DOI: 10.3233/JAD-150642
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472